曲安奈德玻璃体腔注射治疗糖尿病性黄斑水肿17例
被引量:1
摘要
糖尿病性黄斑水肿是糖尿病患者视力下降的主要原因之一,在糖尿病史超过20a的患者中约29%会发生黄斑水肿,其中一半以上患者会在2a的随访中出现视力下降[1]。曲安奈德(TA)是一种长效类固醇激素,玻璃体腔注射此种药物可用于治疗多种原因引起的黄斑水肿。近年来,我们采用TA玻璃体腔注射治疗糖尿病性黄斑水肿17例,取得良好疗效。现报告如下。
出处
《山东医药》
CAS
2014年第39期106-107,共2页
Shandong Medical Journal
参考文献7
-
1丛春霞,李燕.玻璃体腔注射曲安奈德治疗糖尿病性黄斑水肿的临床观察[J].中国实用眼科杂志,2006,24(6):558-561. 被引量:9
-
2许立帅,杨小丽,兰长骏.不同方法注射曲安奈德联合光凝治疗糖尿病性黄斑水肿[J].国际眼科杂志,2014,14(3):435-437. 被引量:11
-
3杨杰,彭振宇,黄慧,彭南祥.激光联合曲安奈德治疗糖尿病黄斑水肿的疗效[J].国际眼科杂志,2013,13(5):960-962. 被引量:10
-
4喻晓兵,师自安,戴虹,龙力.曲安奈德玻璃体注射治疗视网膜分支静脉阻塞继发黄斑水肿[J].中国实用眼科杂志,2006,24(10):1043-1045. 被引量:13
-
5姜燕荣,王凯,黎晓新.曲安奈德玻璃体腔注射治疗视网膜静脉阻塞继发黄斑水肿的疗效观察[J].眼科研究,2006,24(6):639-642. 被引量:18
-
6Jaissle GB, Szurman P, Bartz-Schmidt KU. Ocular side effects and complications of intravitreal triamcinolone acetonide injection [_ J J. Ophthalmology, 2004,101 (2) : 121-128.
-
7Jonas JB, Kreissig I, Degenring RF. Retinal complications of in- travitreal injections of triamcinolone acetonide [ J ]. Graefes Arch Clin Exp Ophthalmol, 2004,242(2) :184-185.
二级参考文献53
-
1姚毅,王志军,姜荔,杨丙建,王玮,张卯年,林顺潮.玻璃体内注射曲安奈德治疗糖尿病性弥漫性黄斑水肿的初步观察[J].中华眼底病杂志,2005,21(4):217-219. 被引量:36
-
2刘武,王景昭.玻璃体内注射曲安奈德的问题与并发症[J].中华眼底病杂志,2005,21(4):267-270. 被引量:39
-
3Pascale Massin,MD. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema. Ophthalmology 2004,111:218-225
-
4A P Ciardella,J Klancnik. Intravitreal triamcinolone for the treatment of refractory diabetic macular edema with hard exudates:an optical coherence tomography study.Br J Ophthalmol 2004,88:1131-1136
-
5Smithen LM,Spaide RF.Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.Am J Ophthalmol. 2004 Nov,138(5):884-5
-
6Rechtman E,Allen VD. Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. Am J Ophthalmol.2003 Oct, 136(4):739-41
-
7Hida T,Chandler D,Arena JE.Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations.Am J Ophthalmol. 1986, 101 : 190-195
-
8Carmen K.M.Chan,MRCP,MRCOphth. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol.2004 Jul, 122(7): 1083
-
9Ziad F.Bashshur,MD. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion.Arch Ophthalmol.2004, 122: 1137-1140
-
10T.Micelli Ferrarl,L.Sborgia. Intravitreal triamcinolone acetonide:valuation of retinal thinkness changes measured by optical coherence tomography in diffuse diabetic macular edema.European Journal of Ophthalmology.2004,321-324
共引文献53
-
1王秀萍.曲安奈德玻璃体腔注射治疗糖尿病性黄斑水肿患者的护理[J].中国实用护理杂志,2007,23(6):21-22. 被引量:1
-
2李九可,李毓敏,沈丽萍,楼定华,童剑萍.玻璃体内注射曲安奈德联合玻璃体切割术治疗玻璃体积血[J].眼科研究,2007,25(10):775-777. 被引量:10
-
3喻晓兵,戴虹,龙力.玻璃体腔曲安奈德注射联合黄斑格栅样光凝治疗糖尿病性弥漫性黄斑水肿[J].中国实用眼科杂志,2007,25(10):1088-1089. 被引量:10
-
4周小煦,吴建国.视网膜静脉阻塞后黄斑水肿的治疗[J].国际眼科杂志,2008,8(2):361-364. 被引量:8
-
5何元,王凤翔,赵高举.绿激光联合曲安奈德治疗视网膜中央静脉阻塞的评估[J].国际眼科杂志,2008,8(5):1029-1030. 被引量:4
-
6关红英,李双农.后Tenon囊下注射曲安奈德后玻璃体腔内药物质量浓度的测定[J].眼科研究,2009,27(6):507-510. 被引量:7
-
7陈吉,姚进,蒋沁,袁南荣.曲安奈德治疗视网膜分支静脉阻塞继发黄斑水肿的疗效评估[J].中国实用眼科杂志,2009,27(6):662-664.
-
8安明,王又,应良.球后注射曲安奈德治疗视网膜静脉阻塞继发黄斑水肿[J].眼科,2009,18(4):254-256. 被引量:4
-
9杨丽敏.曲安奈德离子导入治疗视网膜黄斑水肿的临床观察[J].山东大学耳鼻喉眼学报,2009,23(5):71-72. 被引量:1
-
10崔仁哲,李文吉,郝为华,金龙山.玻璃体腔内注射曲安奈德后早期眼压变化和前房穿刺对眼压的影响[J].眼科研究,2010,28(9):892-895. 被引量:1
同被引文献19
-
1Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema[ J]. Curr Diab Rep,2012,12(4) :346.
-
2Goyal S, Lavalley M, Subramanian ML. Meta-analysis and review on the effect of bevacizumab in diabetic macular edema [ J ]. Graefes Arch Clin Exp Ophthalmo1,2011,249 ( 1 ) : 15 - 27.
-
3Mitchell P, Bandello F, Sehmidt-Erfurth U, et al. The RESTORE study:ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema [ J]. Ophthalmology, 2011, 118(4) :615 -625.
-
4Boyer DS, Hopkins J J, Sorof J, et al. Anti-vascular endothelial growth factor therapy for diabetic macular edema [ J ]. Ther Adv Endocrinol Metab,2013,4(6) :151 - 169.
-
5Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema:results from 2 phase Ⅲ randomized trials:RISE and RIDE [ J]. Ophthalmology ,2012,119 (4) :789 - 801.
-
6Solaiman KA, Diab MM, Abo-Elenin M. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema[ J ]. Retina ,2010,30 ( 10 ) : 1638 - 1645.
-
7Kim YT, Kang SW, Kim SJ, et al. Combination of vitrectomy, IVTA, and laser photocoagulation for diabetic macular edema unresponsive to prior treatments ;3 -year results[ J ]. Graefes Arch Clin Exp Oph- thahno1,2012,250 ( 5 ) :679 - 684.
-
8Zeehmeister-Koss I, Huie M. Vascular endothelial growth factor in- hibitors (anti-VEGF) in the management of diabetic maeular oede- ma:a systematic review[ J]. Br J Ophthalmol,2012,96(2) :167.
-
9Goyal S, Lavalley M, Subramanian ML. Meta-analysis and review on the effect of bevacizumab in diabetic macular edema [ J ]. Graefes Arch Clin Exp Ophthalmol,2011,249 ( 1 ) : 15 - 27.
-
10Bakbak B,Ozturk BT, Gonul S, et al. Comparison of the effect of uni- lateral intravitreal bevacizmnab and ranibizumab injection on diabet- ic macular edema of the fellow eye [ J ]. J Ocul Pharmacol Ther, 2013,29(8) :728 -732.
二级引证文献5
-
1卜莉,韩磊.曲安奈德联合激光光凝治疗糖尿病黄斑水肿患者疗效及对生活质量影响的观察[J].药物流行病学杂志,2017,26(7):446-449. 被引量:6
-
2周洁,周函钰,倪茂巍,程建安.玻璃体腔注射雷珠单抗对比曲安奈德治疗糖尿病性黄斑水肿的Meta分析[J].中国现代应用药学,2018,35(5):719-724. 被引量:9
-
3任红苗,高志娟.黄斑局灶/格栅样光凝术联合雷珠单抗治疗糖尿病性黄斑水肿的疗效[J].国际眼科杂志,2018,18(6):1085-1088. 被引量:8
-
4潘艳杰,查俊华,杨云祥,何迎.雷珠单抗对糖尿病性黄斑水肿的疗效[J].河南医学研究,2020,29(4):654-655. 被引量:1
-
5黄国华,景聪荣,杨芳,张杨.玻璃体腔注射雷珠单抗联合改良格栅激光治疗糖尿病性黄斑水肿的疗效及安全性[J].齐齐哈尔医学院学报,2020,41(23):2947-2948. 被引量:1
-
1张兆国,马文霞,张卫国.雷珠单抗与曲安奈德玻璃体腔注射治疗糖尿病性黄斑水肿的临床疗效[J].世界最新医学信息文摘,2016,16(94). 被引量:1
-
2丁莉娟.激光联合雷珠单抗玻璃体腔注射治疗糖尿病视网膜病变的效果研究[J].河南医学研究,2016,25(9):1676-1677. 被引量:3
-
3杨颖,于文洲.中药联合曲安奈德治疗糖尿病黄斑水肿的临床观察[J].中医临床研究,2016,8(27):62-63. 被引量:2
-
4齐黔方.曲安奈德玻璃体腔注射治疗糖尿病性黄斑水肿的临床研究[J].临床医药实践,2009,18(2Z):1361-1363.
-
5李恒,陈方,苟文军,谢楠,刘全坤,唐碧芳,汪东生.玻璃体腔灌洗联合曲安奈德玻璃体腔注射治疗增殖期糖尿病视网膜病变玻璃体切除术后再出血的疗效观察[J].中华眼科医学杂志(电子版),2016,6(3):103-107. 被引量:7
-
6宋青山,王丁丁,陈子林.两种剂量曲安奈德玻璃体腔注射治疗糖尿病性黄斑水肿的疗效及安全性对比[J].临床眼科杂志,2016,24(3):219-221. 被引量:13
-
7栾春生,韩娟,刘洋,杜金红,高明哲.不同剂量曲安奈得玻璃体腔注射治疗糖尿病性黄斑水肿疗效观察[J].中国误诊学杂志,2010,10(30):7334-7334. 被引量:4
-
8王卫星,彭渝,万安云.曲安奈德玻璃体腔注射治疗糖尿病性弥漫性黄斑水肿[J].南昌大学学报(医学版),2010,50(1):93-94. 被引量:1
-
9董明霞,李冬育,董如娇,赵霞,韩俊莹,陈芳.不同药物玻璃体腔注射治疗弥漫性糖尿病性黄斑水肿的疗效观察[J].中国实用眼科杂志,2015,33(9):980-984. 被引量:15
-
10萨如拉,佟艳秋,赵玉环.玻璃体腔内注射Avastin治疗糖尿病视网膜病变的临床研究[J].国际眼科杂志,2011,11(1):94-96. 被引量:2